Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Carcinoma In Situ × Medroxyprogesterone × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 2 Gynecologic 1

Conditions

Endometrial Neoplasms 2 Paget's Disease, Mammary 1 Endometrial Adenocarcinoma 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Neoplasms 1 Breast Carcinoma In Situ 1

Interventions

Tamoxifen 1 Medroxyprogesterone 1 Immunohistochemistry 1 Fluorescent Antibody Technique 1 Flow Cytometry 1 Fentanyl 1 Chemotherapy, Adjuvant 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed

BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡